{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:18:56Z","timestamp":1793110736830,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"am","delay-in-days":329,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jiac.2025.102712","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T19:13:59Z","timestamp":1745262839000},"page":"102712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Antimicrobial activity of tebipenem to Escherichia coli isolates from outpatients with complicated urinary tract infections"],"prefix":"10.1016","volume":"31","author":[{"given":"Masaya","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6317-9077","authenticated-orcid":false,"given":"Masahiro","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8887-4217","authenticated-orcid":false,"given":"Kaori","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2025.102712_bib1","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1086\/605562","article-title":"Infectious disease hospitalizations in the United States","volume":"49","author":"Christensen","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102712_bib2","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/archinte.163.10.1206","article-title":"Acute pyelonephritis in adults: prediction of mortality and failure of treatment","volume":"163","author":"Efstathiou","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jiac.2025.102712_bib3","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jinf.2015.08.012","article-title":"Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: a matched cohort study","volume":"71","author":"Esteve-Palau","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.jiac.2025.102712_bib4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jiac.2024.03.024","article-title":"Fourth national Japanese antimicrobial susceptibility pattern surveillance program: bacterial isolates from patients with complicated urinary tract infections","volume":"30","author":"Kobayashi","year":"2024","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2025.102712_bib5","series-title":"Antimicrobial resistance threats in the United States, 2021\u20132022","year":"2024"},{"key":"10.1016\/j.jiac.2025.102712_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02240-19","article-title":"In vitro and in vivo characterization of tebipenem, an oral carbapenem","volume":"64","author":"Cotroneo","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2025.102712_bib7","series-title":"Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically","year":"2018"},{"key":"10.1016\/j.jiac.2025.102712_bib8","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2023"},{"key":"10.1016\/j.jiac.2025.102712_bib9","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1128\/JCM.43.7.3309-3313.2005","article-title":"Countrywide spread of community- and hospital-acquired extended-spectrum \u03b2-lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon","volume":"43","author":"Moubareck","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2025.102712_bib10","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1128\/JCM.00765-09","article-title":"Integrated detection of extended-spectrum-beta-lactam resistance by DNA microarray-based genotyping of TEM, SHV, and CTX-M genes","volume":"48","author":"Leinberger","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2025.102712_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01214-22","article-title":"In vitro activity of tebipenem against various resistant subsets of Escherichia coli causing urinary tract infections in the United States (2018 to 2020)","volume":"66","author":"Mendes","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2025.102712_bib12","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1056\/NEJMoa2105462","article-title":"Oral tebipenem pivoxil hydrobromide in complicated urinary tract infection","volume":"386","author":"Eckburg","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2025.102712_bib13","first-page":"75","article-title":"Prevalence and molecular characterization of CTX-M extended-spectrum \u03b2-lactamase-producing Escherichia coli from 2000 to 2010 in Japan","volume":"68","author":"Hara","year":"2015","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.jiac.2025.102712_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jac\/dkg256","article-title":"Effect of D240G substitution in a novel ESBL CTX-M-27","volume":"25","author":"Bonnet","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2025.102712_bib15","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1186\/s12879-021-06735-y","article-title":"Hospitalization for urinary tract infections in Japan, 2010\u20132015: a retrospective study using a national inpatient database","volume":"21","author":"Sako","year":"2021","journal-title":"BMC Infect Dis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25001096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25001096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T11:42:32Z","timestamp":1754480552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X25001096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1341321X25001096"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102712","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial activity of tebipenem to Escherichia coli isolates from outpatients with complicated urinary tract infections","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102712","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102712"}}